Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://matteoeiua919617.blog2freedom.com/39077061/trelaglutide-exploring-a-new-treatment-for-chronic-diseases